This may not sound like a big deal but it is
The current study differs from the study by Wong et al
Well cover the most common mistakes I see in both research and real-world coaching, and more importantly, how to fix each one so you can finally start seeing sustainable fat loss results
Accordingly, we encourage the adoption of GLP-1RA plus SGLT2i combination therapy in patients with T2DM and established atherosclerotic cardiovascular disease (ASCVD) or multiple risk factors for ASCVD (i.e., age 55 years, overweight/obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria)
Alternatively, you can visit and search for the website or pharmacy name
GLP-1 (Glucagon-like peptide-1) medications have recently changed how we manage metabolism and health